Register entry
Medicure International Inc
- Registered sites
- 1
- Drug products
- 6
- Live patents
- 3
- Countries
- 1
- Base
- BRB
Authorisation
Registered operations
What the FDA has registered these sites to do. This is the regulatory record, not a marketing claim.
Finished drug manufacture
Sites
Facilities
1| Site | Location | Operations | FEI |
|---|---|---|---|
| Medicure International Inc. | HoletownBRB | Finished drug manufacture | 3005981418 |
Exclusivity
Patents
3Unexpired Orange Book patents where this company is the application holder.
| Product | Active ingredient | Expiry |
|---|---|---|
| ZYPITAMAG | PITAVASTATIN MAGNESIUM | Jan 2031 |
Catalogue
Marketed products
6Showing 6 of 6.
| Brand | Generic name | Form | Category |
|---|---|---|---|
| AGGRASTAT | TIROFIBAN | INJECTION, SOLUTION | NDA |
| AGGRASTAT | TIROFIBAN | INJECTION, SOLUTION | NDA |
| AGGRASTAT | TIROFIBAN | INJECTION, SOLUTION | NDA |
| AGGRASTAT | TIROFIBAN | INJECTION, SOLUTION | NDA |
| ZYPITAMAG | Pitavastatin Magnesium | TABLET, FILM COATED | NDA |
| ZYPITAMAG | Pitavastatin Magnesium | TABLET, FILM COATED | NDA |
Provenance
Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.